(Q48434410)

11 February 2018

title

Dopaminergic therapies modulate the T-CELL proteome of patients with Parkinson's disease. (English)

1 reference

11 February 2018

1 reference

1 reference

1

1 reference

11 February 2018

Maurizio Zibetti

6

1 reference

11 February 2018

Mauro Fasano

8

1 reference

11 February 2018

Leonardo Lopiano

7

object named as

Leonardo Lopiano

1 reference

11 February 2018

Agnese C Pippione

2

1 reference

11 February 2018

Cristoforo Comi

3

1 reference

11 February 2018

Simone Olgiati

4

1 reference

11 February 2018

Daniela Cecconi

5

1 reference

11 February 2018

publication date

20 July 2012

1 reference

11 February 2018

published in

IUBMB Life

1 reference

11 February 2018

volume

64

1 reference

11 February 2018

issue

10

1 reference

11 February 2018

page(s)

846-852

1 reference

11 February 2018

Missing pieces in the Parkinson's disease puzzle

cites work

1 reference

Parkinson's Disease: Genetics and Pathogenesis

21 January 2018

1 reference

Milestones in Parkinson's disease therapeutics

21 January 2018

1 reference

Current approaches to the treatment of Parkinson's disease

21 January 2018

1 reference

Role of dopamine in the physiology of T-cells and dendritic cells

21 January 2018

1 reference

The immunoregulatory role of dopamine: an update

21 January 2018

1 reference

Inflammation and neurodegeneration in Parkinson's disease

21 January 2018

1 reference

Peripheral biomarkers of Parkinson's disease as early reporters of central neurodegeneration.

21 January 2018

1 reference

Calcium homeostasis is dysregulated in parkinsonian patients with L-DOPA-induced dyskinesias.

21 January 2018

1 reference

Proteomic characterization of Jurkat T leukemic cells after dopamine stimulation: A model of circulating dopamine-sensitive cells.

21 January 2018

1 reference

Proteomics in Parkinson's disease: An unbiased approach towards peripheral biomarkers and new therapies

21 January 2018

1 reference

Integrating genomics, proteomics and bioinformatics in translational studies of molecular medicine.

21 January 2018

1 reference

Using 'omics' to define pathogenesis and biomarkers of Parkinson's disease

21 January 2018

1 reference

Parkinson's disease: clinical features and diagnosis

21 January 2018

1 reference

Proteomic analysis of dopamine and α-synuclein interplay in a cellular model of Parkinson's disease pathogenesis

21 January 2018

1 reference

No increased chromosomal damage in L-DOPA-treated patients with Parkinson's disease: a pilot study

21 January 2018

1 reference

Proteomic analysis of striatal proteins in the rat model of L-DOPA-induced dyskinesia

21 January 2018

1 reference

Cellular models to investigate biochemical pathways in Parkinson's disease

21 January 2018

1 reference

Déjà vu in proteomics. A hit parade of repeatedly identified differentially expressed proteins.

21 January 2018

1 reference

Human prolidase and prolidase deficiency: an overview on the characterization of the enzyme involved in proline recycling and on the effects of its mutations

21 January 2018

1 reference

Aminodipeptidase inhibitor-induced cell death in quiescent lymphocytes: a review

21 January 2018

1 reference

Peroxiredoxin 6, a 1-Cys peroxiredoxin, functions in antioxidant defense and lung phospholipid metabolism

21 January 2018

1 reference

Proteomic analysis reveals that treatment with tocotrienols reverses the effect of H₂O₂ exposure on peroxiredoxin expression in human lymphocytes from young and old individuals.

21 January 2018

1 reference

The physiology, signaling, and pharmacology of dopamine receptors

21 January 2018

1 reference

Neuroinflammation in Parkinson's disease: its role in neuronal death and implications for therapeutic intervention

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/IUB.1073

1 reference

11 February 2018

PubMed ID

22815142

1 reference

11 February 2018